RCEL Company Profile and Key Details

NASDAQ : RCEL

AVITA Medical

$4.44

-0.1771-3.83%

Open: 1:41 PM

67.38

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

AVITA Medical, Inc. (RCEL) stock declined over -3.83%, trading at $4.44 on NASDAQ, down from the previous close of $4.62. The stock opened at $4.70, fluctuating between $4.42 and $4.71 in the recent session.

Stock Snapshot

4.62

Prev. Close

110.37M

Market Cap

4.42

Day Low

-2.55

P/E Ratio

-1.74

EPS (TTM)

-1.25

Cash Flow per Share

4.7

Open

24.84M

Number of Shares

4.71

Day High

97.81%

Free Float in %

2.48

Book Value

62.12K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 16, 2026	4.62	4.78	4.50	4.62	164.52K
Mar 13, 2026	4.61	4.73	4.29	4.40	208.74K
Mar 12, 2026	4.70	4.76	4.52	4.58	147.49K
Mar 11, 2026	4.86	4.99	4.72	4.80	84.79K
Mar 10, 2026	4.98	5.13	4.86	4.90	132.24K
Mar 09, 2026	4.68	5.05	4.64	4.96	166.07K
Mar 06, 2026	4.70	4.86	4.67	4.75	137.16K
Mar 03, 2026	5.12	5.12	4.76	4.81	265.6K
Mar 02, 2026	4.92	5.48	4.90	5.27	261.63K
Feb 27, 2026	5.00	5.18	4.97	5.03	197.37K
Feb 26, 2026	4.93	5.19	4.85	5.11	337.09K
Feb 25, 2026	5.16	5.25	4.99	5.00	256.69K
Feb 24, 2026	4.85	5.92	4.84	5.39	723.61K
Feb 23, 2026	4.79	5.06	4.64	4.85	312.86K
Feb 20, 2026	4.37	4.81	4.25	4.79	313.69K
Feb 19, 2026	4.28	4.42	4.02	4.38	160.47K
Feb 18, 2026	4.29	4.32	4.16	4.31	128.19K
Feb 17, 2026	4.15	4.31	4.06	4.31	178.24K
Feb 13, 2026	3.66	4.43	3.52	4.16	361.86K
Feb 12, 2026	3.84	3.96	3.67	3.72	221.19K

Contact Details

Valencia, CA 91355

United States

https://www.avitamedical.com 661 367 9170

About Company

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 BRKRP

-9-3.29%

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A$264.67 PODD

4.82+2.19%

Insulet Corporation$224.66 UFPT

-0.85-0.42%

UFP Technologies, Inc.$203.02 ALGN

5.22+3.18%

Align Technology, Inc.$169.45 TMDX

1.22+0.99%

TransMedics Group, Inc.$124.70 IRTC

0.77+0.68%

iRhythm Technologies, Inc.$113.77 IRMD

2+2.01%

IRadimed Corporation$101.69 NARI

Inari Medical, Inc.$79.97 AXNX

Axonics, Inc.$70.98

Company Overview

AVITA Medical, Inc. (NASDAQ:RCEL) closed at $4.44 USD, losing -$0.18 (-3.83%) from the previous close of $4.62. The stock is currently mid-range between its 52-week high and low $3.22 and $10.29. With a market capitalization of about $110.37 million, AVITA Medical, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.81). Key stats such as the average daily volume over the past year has been around 225.63 thousand shares, volume is running light vs its 52-week average. Headquartered in Valencia, CA, AVITA Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Cary G. Vance, the company employs approximately 260 people and listed since May 14, 2012. AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom.

Technical Performance

RCEL has shown mixed momentum, gaining 10.23% over the past week and -5.51% over the past quarter, though year-to-date performance is up 9.28%. Short-term trend indicators are mixed aligned (SMA20 17.3%, SMA50 30.48%, SMA200 8.12%). The stock’s 14-day RSI is 66.49 (firm momentum), while the ATR of 0.37 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -50.34% below its high and over 58.7% above its low. Average 10-day trading volume of 150.64 thousand shares is below the 3-month average of 226.51 thousand, indicating normal recent market interest.

Valuation Metrics

AVITA Medical, Inc. trades at a P/E ratio of -2.87, slightly below the S&P 500 average, with a price-to-sales ratio of 1.59 and a price-to-book ratio of -8.39 indicating negative book value, which may reflect financial stress. The P/FCF stands at -3.66, also below market averages.

Dividend & Fair Value

AVITA Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$9.81. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

AVITA Medical, Inc. generated EPS of -$1.75 over the past year. Five-year average earnings growth is 3.38%. The latest quarter delivered EPS of -$0.46. The next quarter is forecast at -$0.28. Next year's EPS is expected at $29.78. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 12 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $22.00 to $3.50. The high target offers 376.19% upside. The low target suggests -24.24% downside. The mean target is $13.03. This offers 182.03% upside. AVITA Medical, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 06, 2025, missed forecasts by 6.98%. The prior quarter beat by 46.15%. Over the last six quarters, Apple has recorded several small beats. These include 1.69% in August 08, 2024.

Shareholding & Insider Activity

AVITA Medical, Inc. has 27.02 million shares outstanding. The public float is 26.06 million shares, elevated short interest at 17.14% of float. This equals 4.60 million shares. The short ratio is 10.99 days. Institutional investors hold 29.4% of the float. Insiders own 0.91%. PERRY MICHAEL S holds 229.54 thousand shares, O'Toole David D has 141.93 thousand shares and McNamara Robert has 86.77 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Financial & Profitability Overview

Over the trailing twelve months, AVITA Medical generated $34.42M in revenue, or $1.38 per share. Gross margin was 82.45%, operating margin -79.91%, and net profit margin -77.47%. Returns are negative, with ROA at -27.14% and ROE at -31.47%.
On valuation metrics, AVITA Medical trades at a P/E of -2.87, P/S of 1.59 and P/B of -8.39. Liquidity is tight, with a current ratio of 0.57 and quick ratio of 0.46. Operationally, the company’s inventory turnover is 1.85 and cash conversion cycle is 243.90 days. Debt-to-equity is -0.13, supported by a cash flow-to-debt ratio of -14.61.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2022, AVITA Medical posted revenue of $34.42M, down slightly from $14.26M in the prior quarter. Gross profit was $28.38M (margin 82.45%). Operating income was - $27.51M (margin -79.9%). Net income was- $26.67M (EPS - $1.07).
The company ended the quarter with $79.34M in cash and short-term investments, a total debt of $918.00K, and net debt of - $17.25M. Total assets were $98.26M, with equity of $0.00. Financials further reflected weakness, with operating cash flow of - $19.09M, free cash flow of - $19.62M, and capital expenditures of - $525.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that AVITA Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 5.41%, with price expected at $4.87 by March 30, 2026, within a range of $4.50 to $5.27 3-Month Outlook: Projected rise of 66.02%, reaching $7.67 by June 12, 2026, with a range of $7.07 to $8.20. 1-Year Outlook: Projected loss of -11.69%, with price at $4.08 by March 16, 2027, within a range of $0.00 to $1.28.

Key Takeaways

AVITA Medical, Inc. (NASDAQ:RCEL) shares are flat 9.28% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows AVITA Medical, Inc. trading at a premium to the broader market with a P/E of -2.87. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $18.58, suggesting 302.16% upside. Our AI forecast model points to short-term strength (5.41% over two weeks), a medium-term rise (66.02% over three months), and a longer-term loss (-11.69% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current AVITA Medical, Inc. (RCEL) stock price?

AVITA Medical, Inc. (NASDAQ: RCEL) stock price is $4.44 in the last trading session. During the trading session, RCEL stock reached the peak price of $4.71 while $4.42 was the lowest point it dropped to. The percentage change in RCEL stock occurred in the recent session was -3.83% while the dollar amount for the price change in RCEL stock was - $0.18.

RCEL's industry and sector of operation?

The NASDAQ listed RCEL is part of Medical - Devices industry that operates in the broader Healthcare sector. AVITA Medical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RCEL?

No Data

How RCEL did perform over past 52-week?

RCEL's closing price is 43.48% higher than its 52-week low of $3.22 where as its distance from 52-week high of $10.29 is -55.1%.

How many employees does RCEL have?

Number of RCEL employees currently stands at 260.

Link for RCEL official website?

Official Website of RCEL is: https://www.avitamedical.com

How do I contact RCEL?

RCEL could be contacted at phone 661 367 9170 and can also be accessed through its website. RCEL operates from 28159 Avenue Stanford, Valencia, CA 91355, United States.

How many shares of RCEL are traded daily?

RCEL stock volume for the day was 62.12K shares. The average number of RCEL shares traded daily for last 3 months was 225.63K.

What is the market cap of RCEL currently?

The market value of RCEL currently stands at $110.37M with its latest stock price at $4.44 and 24.84M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	260
Beta	1.81
Sales or Revenue	$34.42M
5Y Sales Change%	90.609%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

RCEL Company Profile and Key Details

AVITA Medical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook